Ensysce Biosciences (ENSC)
NASDAQ:ENSC
US Market

Ensysce Biosciences (ENSC) Financial Statements

96 Followers

Ensysce Biosciences Financial Overview

Ensysce Biosciences's market cap is currently ―. The company's EPS TTM is $-138.7; its P/E ratio is -0.01; Ensysce Biosciences is scheduled to report earnings on November 13, 2023, and the estimated EPS forecast is $-1.06. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 490.47K$ 789.63K$ 1.43M$ 0.00$ 0.00
Gross Profit$ 490.47K$ 789.63K$ 2.75M--
EBIT$ -2.24M$ 4.15M$ -6.23M$ -9.85M$ -7.89M
EBITDA$ -2.24M$ 4.15M$ -6.23M$ -9.85M$ -7.89M
Net Income Common Stockholders$ -2.24M$ 4.51M$ -5.52M$ -9.90M$ -8.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.83M$ 1.42M$ 3.15M$ 4.50M$ 3.73M
Total Assets$ 6.36M$ 3.91M$ 5.89M$ 8.29M$ 7.95M
Total Debt$ 456.66K$ 19.12K$ 4.74M$ 8.98M$ 2.67M
Net Debt$ -3.37M$ -1.40M$ 1.60M$ 4.47M$ -1.07M
Total Liabilities$ 2.56M$ 4.07M$ 9.91M$ 14.71M$ 8.75M
Stockholders Equity$ 4.08M$ 166.72K$ -3.71M$ -6.09M$ -491.64K
Cash Flow-
Free Cash Flow$ -3.11M$ -3.61M$ -3.30M$ -6.71M$ -4.44M
Operating Cash Flow$ -3.11M$ -3.61M$ -3.30M$ -6.71M$ -4.44M
Investing Cash Flow---$ 0.00$ 0.00
Financing Cash Flow$ 5.52M$ 1.87M$ 1.94M$ 7.48M$ -265.81K
Currency in USD

Ensysce Biosciences Earnings and Revenue History


Ensysce Biosciences Debt to Assets


Ensysce Biosciences Cash Flow


Ensysce Biosciences Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis